These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36374245)

  • 1. Increasing Genome Editing Efficiency of Cas9 Nucleases by the Simultaneous Use of Transcriptional Activators and Histone Acetyltransferase Activator.
    Liu J; Li B; Yang L; Ren N; Xu M; Huang Q
    CRISPR J; 2022 Dec; 5(6):854-867. PubMed ID: 36374245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of histone deacetylase 1 (HDAC1) and HDAC2 enhances CRISPR/Cas9 genome editing.
    Liu B; Chen S; Rose A; Chen D; Cao F; Zwinderman M; Kiemel D; Aïssi M; Dekker FJ; Haisma HJ
    Nucleic Acids Res; 2020 Jan; 48(2):517-532. PubMed ID: 31799598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulating chromatin accessibility by transactivation and targeting proximal dsgRNAs enhances Cas9 editing efficiency in vivo.
    Liu G; Yin K; Zhang Q; Gao C; Qiu JL
    Genome Biol; 2019 Jul; 20(1):145. PubMed ID: 31349852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Chromatin Dynamics on Cas9-Mediated Genome Editing in Human Cells.
    Daer RM; Cutts JP; Brafman DA; Haynes KA
    ACS Synth Biol; 2017 Mar; 6(3):428-438. PubMed ID: 27783893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving CRISPR-Cas9 Genome Editing Efficiency by Fusion with Chromatin-Modulating Peptides.
    Ding X; Seebeck T; Feng Y; Jiang Y; Davis GD; Chen F
    CRISPR J; 2019 Feb; 2():51-63. PubMed ID: 31021236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency.
    Jensen KT; Fløe L; Petersen TS; Huang J; Xu F; Bolund L; Luo Y; Lin L
    FEBS Lett; 2017 Jul; 591(13):1892-1901. PubMed ID: 28580607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and Analysis of Native Chromatin-Modifying Complexes.
    Doyon Y; Côté J
    Methods Enzymol; 2016; 573():303-18. PubMed ID: 27372759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of CRISPR/Cas9 Nuclease in Amphioxus Genome Editing.
    Su L; Shi C; Huang X; Wang Y; Li G
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33167309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Nicotinamide to Culture Medium Improves the Efficiency of Genome Editing in Hexaploid Wheat.
    Wang W; Huang P; Dai W; Tang H; Qiu Y; Chang Y; Han Z; Li X; Du L; Ye X; Zou C; Wang K
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9-Based Genome Editing in Plants.
    Zhang Y; Ma X; Xie X; Liu YG
    Prog Mol Biol Transl Sci; 2017; 149():133-150. PubMed ID: 28712494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient genome editing in wheat using Cas9 and Cpf1 (AsCpf1 and LbCpf1) nucleases.
    Kim D; Hager M; Brant E; Budak H
    Funct Integr Genomics; 2021 Jul; 21(3-4):355-366. PubMed ID: 33710467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temperature effect on CRISPR-Cas9 mediated genome editing.
    Xiang G; Zhang X; An C; Cheng C; Wang H
    J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-viral delivery of genome-editing nucleases for gene therapy.
    Wang M; Glass ZA; Xu Q
    Gene Ther; 2017 Mar; 24(3):144-150. PubMed ID: 27797355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Applications of CRISPR/Cas9-Based Genome Editing in
    Mu Y; Zhang C; Li T; Jin FJ; Sung YJ; Oh HM; Lee HG; Jin L
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361647
    [No Abstract]   [Full Text] [Related]  

  • 16. CRISPR-Cas9 based genome editing for defective gene correction in humans and other mammals.
    Karapurkar JK; Antao AM; Kim KS; Ramakrishna S
    Prog Mol Biol Transl Sci; 2021; 181():185-229. PubMed ID: 34127194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromatin context-dependent effects of epigenetic drugs on CRISPR-Cas9 editing.
    Schep R; Trauernicht M; Vergara X; Friskes A; Morris B; Gregoricchio S; Manzo SG; Zwart W; Beijersbergen RL; Medema RH; van Steensel B
    Nucleic Acids Res; 2024 Aug; 52(15):8815-8832. PubMed ID: 38953163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9: an advanced tool for editing plant genomes.
    Samanta MK; Dey A; Gayen S
    Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of eukaryotic chromatin state on CRISPR-Cas9 editing efficiencies.
    Verkuijl SA; Rots MG
    Curr Opin Biotechnol; 2019 Feb; 55():68-73. PubMed ID: 30189348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems.
    Liu KI; Ramli MNB; Sutrisnoh NB; Tan MH
    Methods Mol Biol; 2018; 1772():267-288. PubMed ID: 29754234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.